Duloxetine Delayed-release Cap Usp 40mg (2c233b3f 83de 40c4 9f1d 81f901f89459 00)
Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 68788-8362
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 68788-8362). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Duloxetine 01)
Figure 1 (Duloxetine 02)
Figure 2 (Duloxetine 03)
This text is a data chart displaying the proportion of patients with relapse and their time from randomization to relapse in days. There is no explanatory text or context provided, so it is not possible to utilize the chart without additional information.*
Figure 3 (Duloxetine 04)
Figure 4 (Duloxetine 05)
Figure 5 (Duloxetine 06)
Figure 6 (Duloxetine 07)
Figure 8 (Duloxetine 08)
This appears to be a table or graph showing the percentage of patients who have experienced improvement in pain, with a column labeled "Percent Improvement in Pain from Baseline". However, the rest of the text is not readable and cannot provide further context or information.*
Figure 9 (Duloxetine 09)
This is a chart showing the percentage of patients improved in pain from baseline (BOCF). The x-axis represents the time period of 1 week, while the y-axis shows the percentage of patients improved on a scale of 0-100.*
Figure 10 (Duloxetine 10)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
